Harvard Apparatus Regenerative Technology
Phase 1FDA’s approval of HRGN’s first IND is an extremely important milestone for HRGN as it will transition Biostage into a clinical stage company
Founded
2013
Focus
Tissue Engineering
About
FDA’s approval of HRGN’s first IND is an extremely important milestone for HRGN as it will transition Biostage into a clinical stage company
Funding History
1Total raised: $12M
Series A$12MUndisclosedMar 15, 2019
Company Info
TypePrivate
Founded2013
LocationHolliston, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile